Doctor's Choice hands out honors

Share this article:
Merck's Fosamax three-page professional ads and Daiichi Sankyo's one-page Evoxac ad took top honors at the Doctors' Choice Awards.

The Fosamax ad, executed by FCB HealthCare, won the generalist physician category, while the Evoxac ad, by Torre Lazur McCann, won the physician specialty category.

In anti-infectives, an ad for Pfizer's Zyvox by Cline, Davis & Mann took top honors. In cardiovascular, an ad for Merck/Schering-Plough's Vytorin, by Surge Worldwide Healthcare, won first place. In psychiatrics, Forest and KPR won for Campral, and in oncologicals, Genentech and Harrison & Star won for an Avastin ad.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.